Patents by Inventor Jessica J. Liu

Jessica J. Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators
    Patent number: 7655670
    Abstract: The present invention is directed to novel 3-spirocyclic indolyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the ORL-1 receptor.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: February 2, 2010
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Kathleen A. Battista, Gilles C. Bignan, Peter J. Connolly, Jessica J. Liu, Steven A. Middleton, Michael J. Orsini
  • Substituted [4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-urea compounds
    Patent number: 7517885
    Abstract: The present invention relates to substituted [4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-urea compounds of Formula (I) and pharmaceutically acceptable forms thereof, as ?1a/?1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said new compounds, new processes to prepare these new compounds and new uses as a medicine as well as methods of treatment.
    Type: Grant
    Filed: June 14, 2006
    Date of Patent: April 14, 2009
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: George Chiu, Peter J. Connolly, Jessica J. Liu, Steven A. Middleton, Virginia L. Pulito, Shengjian Li
  • Substituted isoindole-1,3-diones
    Patent number: 7459557
    Abstract: The present invention relates to substituted isoindole-1,3-dione compounds of Formula (I) and pharmaceutically acceptable forms thereof, as ?1a/?1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said new compounds, new processes to prepare these new compounds and new uses as a medicine as well as methods of treatment.
    Type: Grant
    Filed: June 12, 2006
    Date of Patent: December 2, 2008
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: George Chiu, Peter J. Connolly, Jessica J. Liu, Steven A. Middleton, Virginia L. Pulito, Shengjian Li